Basal Insulin Dose Reduction
Reduce basal insulin by 10-20% when hypoglycemia occurs without a clear identifiable cause. This is the most direct and evidence-based recommendation from the most recent American Diabetes Association guidelines 1.
Primary Recommendation for Hypoglycemia
The 2025 ADA Standards of Care explicitly state that when hypoglycemia occurs and no clear reason can be identified, you should lower the basal insulin dose by 10-20% 1. This applies to both basal analog insulins and NPH insulin during titration and maintenance phases.
Context-Specific Reductions
When Adding Prandial Insulin
If you're adding prandial insulin to an existing basal insulin regimen and the A1C is <8% (<64 mmol/mol), consider lowering the basal dose by 4 units per day or 10% of the basal dose 1. This prevents over-insulinization when intensifying therapy.
When Converting NPH Regimens
When converting from bedtime NPH to a twice-daily NPH plan, use 80% of the current bedtime NPH dose as the total daily dose 1. This represents a 20% reduction to account for the redistribution of insulin timing.
When Adding GLP-1 Receptor Agonists
Research data suggests that when initiating GLP-1 RA therapy alongside basal insulin, expect an average reduction of approximately 8-9 units (roughly 8-10% decrease) over 3 months, though this varies by individual 2. For tirzepatide specifically in type 1 diabetes using automated insulin delivery, consider a 25% reduction in total daily insulin dose at initiation for patients with A1C <7.5% 3.
Clinical Algorithm for Dose Reduction
Step 1: Identify the reason for dose reduction
- Hypoglycemia without clear cause → 10-20% reduction 1
- Adding prandial insulin with A1C <8% → 4 units or 10% reduction 1
- Converting NPH regimens → Use 80% of previous dose 1
- Starting GLP-1 RA therapy → Monitor closely, expect 8-10% reduction over time 2
Step 2: Make the reduction immediately when hypoglycemia occurs
Step 3: Reassess in 3 days and continue titration based on fasting plasma glucose targets
Important Caveats
The 10-20% reduction range allows for clinical judgment. Use the 20% reduction for:
- More severe hypoglycemia episodes
- Recurrent hypoglycemia
- Patients with hypoglycemia unawareness
- Elderly or frail patients
Use the 10% reduction for:
- Single mild hypoglycemic episode
- Patients with significantly elevated glucose levels
- When you need more conservative adjustments
Critical pitfall: Do not reduce basal insulin doses arbitrarily or prophylactically without a specific indication. The guidelines emphasize that dose reductions should be tied to either hypoglycemia events or specific clinical scenarios like regimen intensification 1.